| scholarly article | Q13442814 |
| P2093 | author name string | Arash Keshavarzi Arshadi | |
| Jiann Shiun Yuan | |||
| Milad Salem | |||
| Arash Firouzbakht | |||
| P2860 | cites work | DeepMalaria: Artificial Intelligence Driven Discovery of Potent Antiplasmodials | Q89494123 |
| BioBERT: a pre-trained biomedical language representation model for biomedical text mining | Q90006632 | ||
| AMPL: A Data-Driven Modeling Pipeline for Drug Discovery | Q91531078 | ||
| ATAD5 deficiency alters DNA damage metabolism and sensitizes cells to PARP inhibition | Q91984534 | ||
| The Tox21 10K Compound Library: Collaborative Chemistry Advancing Toxicology | Q101209136 | ||
| FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells | Q104567480 | ||
| The Traditional Medicine and Modern Medicine from Natural Products | Q26748266 | ||
| SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules | Q28090714 | ||
| The evolving role of natural products in drug discovery | Q28236671 | ||
| Virtual screening for the discovery of bioactive natural products | Q28261293 | ||
| Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO) | Q28485179 | ||
| BioCreative V CDR task corpus: a resource for chemical disease relation extraction | Q28603068 | ||
| ChEMBL web services: streamlining access to drug discovery data and utilities | Q28647641 | ||
| Extended-connectivity fingerprints | Q29616639 | ||
| Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania | Q33678681 | ||
| Lassa fever: epidemiology, clinical features, and social consequences | Q33822092 | ||
| Role of natural product diversity in chemical biology | Q33871943 | ||
| PubChem's BioAssay Database | Q34090643 | ||
| A historical overview of natural products in drug discovery. | Q34426191 | ||
| A three-stage biophysical screening cascade for fragment-based drug discovery. | Q35025905 | ||
| Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults | Q35190340 | ||
| Drug targets in infections with Ebola and Marburg viruses | Q37411610 | ||
| STAT1 and STAT3 in tumorigenesis: A matter of balance. | Q38140881 | ||
| Molecular graph convolutions: moving beyond fingerprints. | Q38828100 | ||
| Evaluation of Ebola Virus Inhibitors for Drug Repurposing. | Q38855720 | ||
| A comprehensive map of molecular drug targets. | Q39026969 | ||
| Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo | Q40296138 | ||
| The properties of known drugs. 1. Molecular frameworks | Q40933327 | ||
| Cell-active dual specificity phosphatase inhibitors identified by high-content screening | Q42796341 | ||
| Protein transduction of Rab9 in Niemann-Pick C cells reduces cholesterol storage. | Q46561954 | ||
| Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. | Q47216285 | ||
| The rise of deep learning in drug discovery. | Q49794212 | ||
| The extending spectrum of NPC1-related human disorders: from Niemann-Pick C1 Disease to obesity. | Q50084571 | ||
| MoleculeNet: a benchmark for molecular machine learning. | Q52328539 | ||
| The US Federal Tox21 Program: A strategic and operational plan for continued leadership. | Q52660630 | ||
| DeepTox: Toxicity Prediction using Deep Learning | Q55920548 | ||
| Artificial Intelligence for Drug Discovery, Biomarker Development, and Generation of Novel Chemistry | Q57059750 | ||
| Use of Favipiravir to Treat Lassa Virus Infection in Macaques | Q58777764 | ||
| P4510 | describes a project that uses | BioBERT | Q112063555 |
| P433 | issue | 1 | |
| P304 | page(s) | 10 | |
| P577 | publication date | 2022-03-07 | |
| P1433 | published in | Journal of Cheminformatics | Q6294930 |
| P1476 | title | MolData, a molecular benchmark for disease and target based machine learning | |
| P478 | volume | 14 |
Search more.